
James C. McAllister III, MS, FASHP
Articles by James C. McAllister III, MS, FASHP


With a lack of staff and resources to help determine what drugs are used in busy clinics and to document standard protocols prescribed in them, perhaps a starting strategy is to enlist the help of professional students or pharmacy residents.






Diverse practice settings and avoiding cumbersome new bureaucratic requirements should be taken into account when developing evidence-based health care guidelines.

The election of the new president ushered in the theme, "a time for change." Pharmacy needs to stay abreast of these changes and plan and react accordingly.

The use of drugs for unapproved indications is frequently discussed and sometimes causes great angst in hospitals and health systems.

Regulatory intervention may be necessary in order to guarantee the quality of compounded intravenous medications.

As a new administration prepares to take office, now is the time for pharmacists to be proponents of the change promised for health care.

The recent controversy of pharmaceuticals found in drinking water has raised questions about the proper disposal of pharmaceuticals.


Pharmacy leaders and practicing pharmacists should realize the expertise and professional commitment that IV admixture pharmacists bring to hospital departments.


Certain events impact the patient?provider relationship and need to be monitored to ensure appropriate oversight of drug therapy.

As preceptors, practitioners have the opportunity to model the shape of the profession's future; however, several items are threatening this historical practice—how can we reverse this trend?

Many recent news items have raised questions regarding the quality of the pharmaceutical supply; solving this will be a challenge, but suggestions are presented here.

Pharmacy's advocacy for optimizing medication use and dedication to caring for patients should be a global, profession-wide commitment.

Is a third class of drugs on the horizon for pharmacy?

"Ain't no stopping us now"?ASHP meeting highlights 2007 accomplishments and looks to bright future.

Can we develop strategies in our departments?

Mr. McAllister is director of pharmacy at University of North Carolina Hospitals and Clinics.

Mr. McAllister is Pharmacy Times Editor, Health-systems Pharmacy Section and director of pharmacy at University of North Carolina Hospitals and Clinics.





Latest Updated Articles
Experiential Education: Stepping Up to the PlatePublished: January 25th 2012 | Updated:
Developing Patient-Specific Clinic ProtocolsPublished: December 28th 2009 | Updated:
Biosimilars and Health Care ReformPublished: October 15th 2009 | Updated:
Supporting Our Professional AssociationsPublished: June 15th 2009 | Updated:
Expanding FDA Regulation of Tobacco ProductsPublished: July 15th 2009 | Updated:
Health Systems Pharmacy Editor's Note: Minimizing Prescription Drug AbusePublished: August 15th 2009 | Updated:





